A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST

Clinical trial NCT02776878 · UNKNOWN

Trial details

NCT number: NCT02776878
Sponsor: Peking University Cancer Hospital & Institute
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumor

Start date: 2016-05-01
Primary completion: 2017-10-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.